Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stuart P. Turner is active.

Publication


Featured researches published by Stuart P. Turner.


Hypertension | 2009

Heterogeneity of L- and T-Channels in the Vasculature: Rationale for the Efficacy of Combined L- and T-Blockade

Christine J. Ball; David Wilson; Stuart P. Turner; David A. Saint; John F. Beltrame

Clinical studies suggest that T-type Ca2+ channel blockade may have incremental benefits over conventional L-channel blockade, particularly in microvascular disorders. This study examined functional vasomotor differences in L- and T-channel blockade between large and small vessels and compared the abundance of the L- and T-type channels in these vessels. The inhibition of endothelin-1 and potassium-induced vascular contractile responses by L-channel blockers (verapamil and nifedipine) was compared with combined L- and T-channel blockers (mibefradil and efonidipine) in large (rat aorta) and small (rat mesenteric and human subcutaneous) vessels using wire myography. All 4 of the Ca2+ channel blockers inhibited contractile responses to a similar extent in large rat vessels; however, in rat microvessels, the combined L- and T-channel blockers produced significantly greater inhibition of contraction than L-channel blockers alone. The significance of this differential T-channel effect in microvessels was further supported by the following: (1) a greater abundance of T-channels compared with L-channels in microvessels but not in large vessels; (2) demonstration of divergent Ca2+ channel blocker responses in human microvessels; (3) incremental inhibition of constrictor responses with combined L- and T-Ca2+ channel blockers despite maximal L-channel blockade; (4) the use of structurally diverse Ca2+ channel blockers with varied affinity for L- and T-channels; (5) the use of pharmacodynamically and therapeutically appropriate Ca2+ channel blocker concentrations; (6) confirmation of contractile agonist independent responses; and (7) exclusion of an endothelium-dependent mechanism. We propose that T-type channels play an important role in regulating contractile responses in the microvasculature and, therefore, are a potential therapeutic target.


Hypertension | 2009

Response to Is Combined L- and T-Channel Blockade Better than L-Channel Blockade in Therapy?

David Wilson; Christine J. Ball; Stuart P. Turner; David A. Saint; John F. Beltrame

We acknowledge and endorse the comments made by Godfraind1 that the response to Ca2+ channel blockers is multifactorial. However, our data indicate that regional differences in Ca2+ L- and T-channel abundance may be important additional mechanisms that account for differential responses to Ca2+ channel blockers. Data from our previous and …


Journal of the American College of Cardiology | 2004

The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon.

John F. Beltrame; Stuart P. Turner; Sue Leslie; Patty Solomon; S. B. Freedman; John D. Horowitz


Journal of The American Society of Echocardiography | 2004

Quantitative assessment of aortic sclerosis using ultrasonic backscatter

Doan T.M. Ngo; Ronald D. Wuttke; Stuart P. Turner; Thomas H. Marwick; John D. Horowitz


American Journal of Cardiology | 2001

Persistence of the coronary slow flow phenomenon

John F. Beltrame; Stuart P. Turner; John D. Horowitz


American Heart Journal | 2003

Mibefradil: "Has the baby been thrown out with the bath water?".

John F. Beltrame; Stuart P. Turner; Sue Leslie; John D. Horowitz


/data/revues/14439506/v12i2/S1443950603902058/ | 2011

Beneficial effects of mibefradil in the control of angina associated with the coronary slow flow phenomenon. A randomised, double-blind, placebo-controlled, crossover study

John F. Beltrame; Stuart P. Turner; Susan Leslie; Patty Solomon; S. B. Freedman; John D. Horowitz


Archive | 2010

phenomenon The angiographic and clinical benefits of mibefradil in the coronary slow flow

John D. Horowitz; John F. Beltrame; Stuart P. Turner; Susan Leslie; Patricia J. Solomon; Saul Benedict Freedman


Heart Lung and Circulation | 2003

Mibefradil accelerates angiographic coronary flow in the coronary slow flow phenomenon

Stuart P. Turner; John F. Beltrame; Michael B. Taylor; John D. Horowitz

Collaboration


Dive into the Stuart P. Turner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sue Leslie

University of Adelaide

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge